X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (74) 74
index medicus (56) 56
female (49) 49
cancer (45) 45
oncology (45) 45
male (43) 43
mutation (41) 41
middle aged (38) 38
aged (35) 35
life sciences (34) 34
lung neoplasms - genetics (29) 29
lung cancer (26) 26
adult (24) 24
aged, 80 and over (20) 20
carcinoma, non-small-cell lung - genetics (17) 17
prognosis (17) 17
tumors (17) 17
adenocarcinoma (16) 16
colorectal cancer (16) 16
mutations (16) 16
lung neoplasms - pathology (15) 15
pathology (14) 14
receptor, epidermal growth factor - genetics (14) 14
adenocarcinoma - genetics (13) 13
colorectal neoplasms - genetics (13) 13
genetic aspects (13) 13
neoplasm staging (13) 13
ras proteins - genetics (13) 13
proto-oncogene proteins - genetics (12) 12
proto-oncogene proteins p21 (12) 12
respiratory system (12) 12
therapy (12) 12
chemotherapy (11) 11
kras (11) 11
research (11) 11
biomarkers (10) 10
carcinoma, squamous cell - genetics (10) 10
deoxyribonucleic acid--dna (10) 10
genotype (10) 10
microsatellite instability (10) 10
patients (10) 10
analysis (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
biochemistry, molecular biology (9) 9
braf (9) 9
cetuximab (9) 9
circulating tumor dna (9) 9
colorectal-cancer (9) 9
gefitinib (9) 9
gene (9) 9
growth-factor receptor (9) 9
prospective studies (9) 9
resistance (9) 9
treatment outcome (9) 9
alleles (8) 8
carcinoma (8) 8
cohort studies (8) 8
diagnosis (8) 8
disease-free survival (8) 8
france (8) 8
gene mutations (8) 8
genes (8) 8
head and neck neoplasms - genetics (8) 8
human health and pathology (8) 8
kinases (8) 8
medicine (8) 8
polymerase chain reaction (8) 8
proto-oncogene proteins b-raf - genetics (8) 8
survival (8) 8
[ sdv.can ] life sciences [q-bio]/cancer (7) 7
antineoplastic agents - therapeutic use (7) 7
biomarkers, tumor - genetics (7) 7
carcinoma, non-small-cell lung - pathology (7) 7
classification (7) 7
colorectal neoplasms - diagnosis (7) 7
colorectal neoplasms - drug therapy (7) 7
egfr (7) 7
egfr mutations (7) 7
epidermal growth factor receptors (7) 7
expression (7) 7
genetics (7) 7
genetics & heredity (7) 7
genomics (7) 7
lung cancer, non-small cell (7) 7
metastasis (7) 7
mutation - genetics (7) 7
reproducibility of results (7) 7
retrospective studies (7) 7
care and treatment (6) 6
development and progression (6) 6
epidermal growth factor (6) 6
health aspects (6) 6
metastases (6) 6
next-generation sequencing (6) 6
non-small cell lung cancer (6) 6
plasma (6) 6
risk factors (6) 6
smoking (6) 6
studies (6) 6
1st-line treatment (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Human Genetics, ISSN 1018-4813, 06/2006, Volume 14, Issue 6, pp. 773 - 779
Journal Article
Haematologica, ISSN 0390-6078, 04/2013, Volume 98, Issue 4, pp. 649 - 654
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1415 - 1426
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2013, Volume 132, Issue 9, pp. 2217 - 2221
In eukaryotic cells, DNA is packaged into chromatin and this compact storage in the nucleus promotes transcriptional repression of genes. Chromatin remodeling... 
mutation | non‐small cell lung carcinoma | ARID2 | JARID2 | chromatin remodeling gene | non-small cell lung carcinoma | PATHWAYS | SWI/SNF COMPLEX | LANDSCAPE | CANCER | SOMATIC MUTATIONS | EGFR | FREQUENT MUTATIONS | GENE | ONCOLOGY | Polycomb Repressive Complex 2 - genetics | Prognosis | Oligonucleotide Array Sequence Analysis | Adenocarcinoma, Bronchiolo-Alveolar - pathology | Carcinoma, Large Cell - pathology | Humans | Middle Aged | Molecular Sequence Data | Lung Neoplasms - pathology | Male | Gene Expression Profiling | Adenocarcinoma, Bronchiolo-Alveolar - genetics | Base Sequence | Polymerase Chain Reaction | Adult | Female | Carcinoma, Large Cell - genetics | Real-Time Polymerase Chain Reaction | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | RNA, Messenger - genetics | Chromatin Assembly and Disassembly | Transcription Factors - genetics | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Polymorphism, Single Nucleotide - genetics | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Neoplasm Staging | Carcinoma | Genes | Genomics | Melanoma | Genetic transcription | Lung cancer, Non-small cell | Liver cancer | Gene mutations | Analysis | Genetic aspects | Tumor proteins | Xenobiotics | Hepatitis C virus | Health aspects | Cancer | Chromatin | Genomes | Mutation | Gene expression | Lung cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 862 - 873
Summary Background Since the 1990s, fluorouracil-based adjuvant chemotherapy has significantly reduced the risk of tumour recurrence in patients with stage III... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | THERAPY | ONCOLOGY | BEVACIZUMAB | ADJUVANT TREATMENT | NSABP C-07 | KRAS | COMBINATION | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Diarrhea - chemically induced | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Infusions, Intravenous - adverse effects | Adult | Female | Leucovorin - therapeutic use | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | Cetuximab | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Exons - genetics | Proto-Oncogene Proteins - genetics | Adenocarcinoma - drug therapy | Mucositis - chemically induced | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Intention to Treat Analysis | Aged | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - surgery | Prevention | Care and treatment | Chemotherapy | Colon cancer | Hospitals | Leucovorin | Product development | Cancer | Life Sciences
Journal Article
Chemistry – A European Journal, ISSN 0947-6539, 08/2018, Volume 24, Issue 46, pp. 11922 - 11925
The peri‐iodo naphthyl phosphine 1 reacts with CuI to give the peri‐bridged phosphonio‐naphthalene 2, which has been fully characterized (multi‐nuclear NMR,... 
copper | P−C coupling | naphthalene | strained ring | phosphorus | HALIDES | GOLD | CATALYZED SYNTHESIS | COMPLEXES | REACTIVITY | BOND FORMATION | OXIDATIVE ADDITION | CHEMISTRY, MULTIDISCIPLINARY | H ACTIVATION | LIGANDS | P-C coupling | Gold | Naphthalene | Nuclear magnetic resonance--NMR | Copper | Aromatic compounds | Phosphine | or physical chemistry | Analytical chemistry | Polymers | Material chemistry | Chemical Sciences | Theoretical and
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 16, pp. 1997 - 2003
Journal Article